Aperio Technologies, Inc. has launched TMALab II, the latest release of the company’s web-based digital pathology information management system, built specifically for researchers who use Tissue ...

Friday, December 6, 2024. News & Perspective ...

Todd Huffman is the CEO of 3Scan, a company that is building automated microscopy tools and software for large-scale tissue analysis (Full disclosure: my venture firm Lux Capital is an equity ...

March 15, 2006 (Vol. 26, No. 6) Emphasis on Potential Clinical Applications and Enhancing RNA Sample Quality Researchers are beginning to look at tissue microarrays (TMA) from different ...

Analysis of histological sections of disease tissues has traditionally relied on pathologist-based scoring. In an Advanced Online Publication in Nature Medicine Camp et al. describe techniques to ...

Analysis of the contribution of macrophages to the overall tumor PD-L1 microenvironment using a screening multi-tumor tissue microarray and rapid multiplex fluorescence digital phenotyping approach.

To study tissue samples from multiple patients, researchers use tissue microarrays (TMAs), a technology in which hundreds of tissue cores are arranged on a single glass slide for analysis by ...

Tissue-based assay optimization is typically performed using a few (<10) representative whole-tissue samples to ensure assay specificity and sensitivity. This is typically a subjective process ...

Todd Huffman is the CEO of 3Scan, a company that is building automated microscopy tools and software for large-scale tissue analysis (Full disclosure: my venture firm Lux Capital is an equity ...